USP9X被鉴定为白血病易感基因
该研究对具有出生缺陷和癌症的先证者及其父母进行全基因组测序,发现一名患多种出生缺陷、发育迟缓和B细胞急性淋巴细胞白血病(B-ALL)的女性先证者携带USP9X催化域内5 kb新发杂合框内缺失。在42名女性先证者中,携带B-ALL者(n=3)聚集于USP9X功能缺失变异伴多发畸形者,其B-ALL累积发病率为7.1%,显著高于年龄性别匹配队列的0.003%(P<.0001)。
要点
- USP9X被描述为女性特异性白血病易感基因,与多发先天畸形、神经发育异常及B-ALL风险相关。
- 女性USP9X功能缺失变异先证者B-ALL累积发病率为7.1%,显著高于匹配队列的0.003%(P<.0001)。
- 在散发性儿童B-ALL中,USP9X作为抑癌基因,低表达与高危B-ALL患者较差生存相关。
核心结论
- USP9X被描述为一种新的女性特异性白血病易感基因,与多发先天畸形、神经发育异常及B-ALL风险相关。
- 在散发性儿童B-ALL中,USP9X在男女两性中均作为抑癌基因,低表达与高危B-ALL患者较差生存相关。
研究设计与样本
- 对来自出生缺陷与癌症研究队列的先证者及其父母进行全基因组测序,并进行结构变异分析。
- 基因型-表型分析纳入既往报道的女性先证者(n=42)。
- 将女性先证者B-ALL累积发病率与监测、流行病学和最终结果数据库(Surveillance, Epidemiology, and End Results database)中年龄和性别匹配队列进行比较。
主要发现
- 在一名患多种出生缺陷、发育迟缓和B-ALL的女性先证者中,结构变异分析发现一个5 kb的新发杂合框内缺失,覆盖USP9X催化域。
- 该女性先证者表型与女性限制性X连锁综合征性智力发育障碍-99(MRXS99F)一致。
- 基因型-表型分析显示,携带B-ALL的MRXS99F女性先证者(n=3)与携带USP9X功能缺失(LoF)变异及多发畸形者聚类。
- 这些女性先证者中B-ALL累积发病率为7.1%,显著高于年龄和性别匹配队列的0.003%(P<.0001,对数秩检验)。
- 在散发性B-ALL中,USP9X体细胞LoF突变在男女两性中均发生,且两性白血病样本中表达水平相当(P=.54),表达最高者为X染色体额外拷贝的女性患者。
关键数值与推荐
- 女性先证者中B-ALL累积发病率为7.1%,年龄和性别匹配队列为0.003%(P<.0001,对数秩检验)。
- 散发性B-ALL男女两性白血病样本中USP9X表达水平比较P=.54。
- 男性功能缺失变异尚无报道;男性携带亚效错义变异者表现为神经发育障碍而无出生缺陷或白血病风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We recently reported that children with multiple birth defects have a significantly higher risk of childhood cancer. We performed whole-genome sequencing on a cohort of probands from this study with birth defects and cancer and their parents. Structural variant analysis identified a novel 5 kb de novo heterozygous inframe deletion overlapping the catalytic domain of USP9X in a female proband with multiple birth defects, developmental delay, and B-cell acute lymphoblastic leukemia (B-ALL). Her phenotype was consistent with female-restricted X-linked syndromic intellectual developmental disorder-99 (MRXS99F). Genotype-phenotype analysis including previously reported female probands (n = 42) demonstrated that MRXS99F probands with B-ALL (n = 3) clustered with subjects with loss-of-function (LoF) USP9X variants and multiple anomalies. The cumulative incidence of B-ALL among these female probands (7.1%) was significantly higher than an age- and sex-matched cohort (0.003%) from the Surveillance, Epidemiology, and End Results database (P < .0001, log-rank test). There are no reports of LoF variants in males. Males with hypomorphic missense variants have neurodevelopmental disorders without birth defects or leukemia risk. In contrast, in sporadic B-ALL, somatic LoF USP9X mutations occur in both males and females, and expression levels are comparable in leukemia samples from both sexes (P = .54), with the highest expressors being female patients with extra copies of the X-chromosome. Overall, we describe USP9X as a novel female-specific leukemia predisposition gene associated with multiple congenital, neurodevelopmental anomalies, and B-ALL risk. In contrast, USP9X serves as a tumor suppressor in sporadic pediatric B-ALL in both sexes, with low expression associated with poorer survival in patients with high-risk B-ALL.
引用
- Sisoudiya SD, Mishra P, Li H, et al. Identification of USP9X as a leukemia susceptibility gene. Blood Adv. 2023. PMID: 37289514. doi:10.1182/bloodadvances.2023009814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。